
SignificanceExcess Toll-like receptor 2 (TLR2) signaling has been implicated in numerous inflammatory diseases, yet there is no TLR2 inhibitor licensed for human use. Using computer-aided drug design (CADD), we identified a compound, C16H15NO4(C29), and a derivative,ortho-vanillin, that inhibit TLR2 signaling in vitro and in vivo. Our findings also revealed unexpected differences between TLR2/1 and TLR2/6 signaling in mice vs. humans. Importantly, our data provide proof of principle that the CADD-targeted BB loop pocket residues are critical for TLR2 signaling and may be targeted therapeutically.
Inflammation, Interleukin-8, Anti-Inflammatory Agents, Drug Evaluation, Preclinical, Toll-Like Receptor 1, Antioxidants, Toll-Like Receptor 2, Protein Structure, Tertiary, Mice, HEK293 Cells, Toll-Like Receptor 6, Benzaldehydes, Drug Design, Animals, Humans, RNA, Messenger, Signal Transduction
Inflammation, Interleukin-8, Anti-Inflammatory Agents, Drug Evaluation, Preclinical, Toll-Like Receptor 1, Antioxidants, Toll-Like Receptor 2, Protein Structure, Tertiary, Mice, HEK293 Cells, Toll-Like Receptor 6, Benzaldehydes, Drug Design, Animals, Humans, RNA, Messenger, Signal Transduction
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 151 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
